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Abstract: 
 Previous work from our laboratory demonstrated that obese mice have alterations in anti-           
viral cytokine gene expression when infected with the influenza virus. Since these cytokines play 
a major role in the infected cells’ innate immune response, we evaluated the effects of leptin dos-
age on expression of several cytokines during a flu infection in human alveolar lung epithelium 
(A549 cells). Following 48 hours of infection by influenza A/Puerto Rico/8/1934 H1N1, increas-
ing leptin dosage resulted in significant decreases in expression of interferon-α (IFNα) and 
monocyte chemotactic protein-1 (MCP-1); a strong, similar trend was found for IFNβ, but it was 
not statistically significant. No leptin dosage trends were found for IL-6 or for the amount of 
viral particles released by cells into the supernatant. These data suggest that leptin contributes to 
the increased flu severity in obese individuals by weakening the innate immune response. 
I. Aims    
 Obesity is epidemic throughout the United States and is known to increase the risk of a 
variety of medical complications, including cardiovascular disease, diabetes, and multiple can-
cers1. More recently, obesity has been found to be an independent risk factor for severe compli-
cations, hospitalizations, and death due to infection with the influenza virus2. As the rates of obe-
sity rise, annual deaths from flu infections may increase, and flu pandemics may end up being 
even more deadly than in the past. This leads us to ask why does obesity lead to increased sus-
ceptibility to flu infection? What is it about the obese state that could affect the flu severity and 
mortality? One possibility is elevated leptin levels.  
 We, and others, have demonstrated that leptin levels are significantly elevated in the 
serum of obese animals. However, our lab has uniquely demonstrated that leptin levels are also 
elevated in lung lavage fluid during flu infection in obese mice, revealing that the lung epithelial 
cells are bathed in abnormal levels of leptin. This finding raises the question: does leptin only 
affect the immune response or does it also affect the influenza virus pathology and the hardiness 
of the lung tissue? 
Aim 1: Determine the role of leptin dosage on the innate immune response of human lung tissue 
(A549 cells) during influenza infection 
 a. Evaluate the tissue’s ability to recruit leukocytes. We hypothesize that with increas-                
ing leptin dosage, human lung tissue will have an impaired expression of MCP-1. 
 b. Evaluate the tissue’s ability to repel infections. We hypothesize that with increasing                 
leptin dosage, human lung tissue will have an impaired expression of IFNα and IFNβ. 
 c. Evaluate the tissue’s release of pro-inflammatory cytokines. We hypothesize that                 
with increasing leptin dosage, human lung tissue will have an excessive expression of IL-6. 
Aim 2: Determine the role of leptin dosage on the innate immune response of canine kidney 
tissue (MDCK cells) during influenza infection 
 a. Evaluate the tissue’s ability to recruit leukocytes. We hypothesize that with increas-                
ing leptin dosage, canine kidney tissue will have an impaired expression of MCP-1. 
 b. Evaluate the tissue’s ability to repel infections. We hypothesize that with increasing                 
leptin dosage, canine kidney tissue will have an impaired expression of IFNα and IFNβ. 
 c. Evaluate the tissue’s release of pro-inflammatory cytokines. We hypothesize that                 
with increasing leptin dosage, canine kidney tissue will have an excessive expression of IL-6. 
Aim 3: Determine the role of leptin dosage on viral titers during influenza infection 
 a. Evaluate the effects of leptin on the replication of the flu virus. We hypothesize that                 
with increasing leptin dosage, flu virus will be present at greater levels. 
The overall objective of this research is to determine the effects of leptin on the flu res-
ponse: leptin’s ability to alter the innate immune response to the flu in human epithelial tissue, 
and the effects on virus titers. Results from this study can help explain why obese individuals are 
more susceptible to influenza virus infection compared with healthy weight individuals. With the 
information gained from this study, we can attempt to identify mechanisms that cause increased 
flu severity in obese populations and find ways to strengthen infected tissues’ response to infec-
tion for a proper reaction to the flu. 
II. Introduction 
Leptin, a polypeptide signaling molecule synthesized primarily by adipocytes, is present 
in the blood in proportion to the amount of adipose tissue in the human body3. Lean humans have 
leptin concentrations around 10 ng/mL whereas obese humans have leptin concentrations around 
35 ng/mL—more than three times the former10. Once thought to be a cure for obesity due to its 
role in suppressing appetite, leptin has been found to be pleiotropic, having many effects on 
many tissues in the body. Leptin is a necessary hormone for hunger inhibition and regulation of 
adiposity, but it also plays a role in immunomodulation, regulatory T-cell suppression, insulin 
resistance, and pro-inflammatory responses3,4. Furthermore, studies indicate that leptin may have 
even more functions in the body: leptin receptor mRNA variants have been isolated in a wide 
range of tissue types, including the spleen, kidneys, testes, liver, and adrenal glands5.  
Our lab has studied the effects of obesity on the response to infection with influenza 
virus. Using a mouse model of diet-induced obesity, we found that obese mice have a 60% 
mortality rate from influenza infection, compared with a 10% mortality rate with lean mice, 
mirroring the effects of obesity on infection in humans. In obese mice, it has been demonstrated 
that the T-cell memory response is weakened when infected with influenza virus and the lung tis-
sue has an increased pathology6. Though we have found that obesity can influence the immune 
response, we also found that mouse lung epithelial cells failed to make mRNA for the anti-viral 
cytokines interferon alpha and interferon beta7. In addition, the cells’ inflammatory cytokine pro-
duction was seriously delayed. These data suggest that obesity has an effect on lung epithelial 
cells, perhaps making them more susceptible to influenza infection. 
Lung epithelial cells have leptin receptors on their membranes, evidencing that leptin 
signaling must occur in the lung tissue. The functions of those receptors and the signals they 
transduce are currently unknown, though they may play a role in the remodeling of airways and 
response to inflammation8. In addition, mice with elevated leptin levels in the body exhibit res-
piratory distress and other respiratory dysfunction, however these could possibly be due to obe-
sity itself and not due to the increased leptin levels9. Since obese individuals have elevated circu-
lating levels of leptin, which is an immunomodulating inflammatory molecule, and have in-
creased flu-related complications, we predict that the excess leptin found in obese persons is a 
contributing factor to the increased severity of flu infection in obese individuals. We also predict 
that leptin will have similar effects in other infected tissues, such as kidney tissue. 
III. Methods 
Cell lines and leptin exposures 
We used two different cell lines for this study. First, we began with A549 cells, human alveolar 
basal epithelial cells, which were grown in culture and subsequently infected with influenza 
virus. These cells were separated into three distinct groups and treated as follows: 1) no leptin, 2) 
leptin concentration 10 ng/mL, and 3) leptin concentration 100 ng/mL. Group 1 represents the 
controls and group 2 represents lean individuals10. Group 3 represents extreme levels not usually 
seen in the serum of healthy humans; however these concentrations may occur locally at the cell-
ular level. All cells were exposed to purified recombinant human leptin for 24 hours prior to in-
fection. This protocol was repeated using Madin-Darby canine kidney (MDCK) epithelial cells in 
order to see if leptin has similar effects on different types of tissues. Both A549 and MDCK cells 
are routinely used to study and grow influenza viruses. 
Influenza infection and RNA isolation 
Following the leptin exposure, cells were infected with influenza A/Puerto Rico/8/1934 H1N1 
(A/PR8) virus. After 8 hours of infection at 37ºC, the supernates were removed and stored at 
-80ºC; the cells were lysed with TRIzol reagent (Invitrogen) and the RNA was isolated. Unin-
fected cells will be treated in the same manner as the infected cells to use a control for the leptin 
exposure. The RNA isolated for all samples was transcribed to cDNA with Oligo(dT)-primed 
reverse transcription using SuperScript II Reverse Transcriptase (Invitrogen).  
Gene expression quantitation 
Cell mRNA levels were measured for IFNα and IFNβ, IL-6, and MCP-1 genes using a BioRad 
CFX96 Real-Time PCR iCycler. The primers and probes for these assays were designed by 
Applied Biosystems for a TaqMan gene expression assay.The mRNA transcripts for GAPDH 
were also determined for all samples to normalize gene expression, allowing for a calculation of 
fold increase based on the cycle number at which the sample passed a threshold value. Fold in-
crease was expressed as a fold of uninfected, leptin-free samples at 8 hours of incubation when 
available. In samples with no 8-hour data, the fold increase was expressed as fold of the unin-
fected, leptin-free group for that gene and time-point.  
Virus quantification 
Influenza A/PR8 virus titers were measured in the supernatant (a measure of released virus) by a 
modified TCID50 assay with hemagglutination as an endpoint indicator. 
Statistical analysis  
Measures of significance were analyzed via two-way ANOVA; p values of less than 0.05 were 
considered statistically significant. 
IV. Results 
High leptin exposure results in reduced expression of antiviral cytokines 
At 48 hours post-infection, leptin exposure resulted in a significant decrease in expression of 
IFNα mRNA; the decrease in IFNβ is similar but not statistically significant. It should be noted 
that at 48 hours, the average fold increase in the expression of IFNα for infected 100 ng/mL lep-
tin samples were weaker than the average increase 10 ng/mL leptin samples while uninfected 
(Figure 1). This finding implies that the infected “obese” samples had such a weak response that 
they were behaving as if they were not infected in the first place. After 48 hours of incubation, 
the relative expression of IFNα between infected and uninfected cells increased an average 7.7-
fold in the leptin-free samples, 5.3-fold in the 10 ng/mL leptin samples, and 3.2-fold in the 100 
ng/mL leptin samples. For IFNβ, expression in infected cells increased 38-fold in the leptin-free 
samples, 20-fold in the 10 ng/mL leptin samples, and 18-fold in the 100 ng/mL leptin samples. 
These data indicate that the ratio of expression fold increase brought about by infection is also 
weakened by leptin in addition to the absolute expression increase of these genes. IFNα and 
IFNβ have direct roles in the inhibition of viral replication and the activation of cytotoxic natural 
killer cells for destruction of infected tissue12—arguably the most important aspects of the cell’s 
inherent protections against viral infection. According to these data, the leptin-induced deficit in 
antiviral cytokines does not occur until 48 hours post-infection, which is approximately at the 
onset of symptoms for most flu strains13. 
 
Figure 1. Effects of leptin on human alveolar lung tissue expression of the IFNα gene after 8, 24, 
and 48 hours of influenza A/PR8 virus infection, measured by quantitative RT-PCR from total 
RNA. After 48 hours of infection, the leptin dosage as a significant effect on IFNα mRNA 
expression (p = 0.0062). 
 
Figure 2. Effects of leptin on human alveolar lung tissue expression of the IFNβ gene after 8, 24, 
and 48 hours of influenza A/PR8 virus infection, measured by quantitative RT-PCR from total 
RNA. After 48 hours of infection, the leptin dosage has a nearly significant effect on the increase 
of IFNβ mRNA expression (p = 0.0610). 
High leptin exposure results in reduced expression of MCP-1 
Following 48 hours of A549 tissue infection, there was a significant trend of reduced gene ex-
pression as a result of leptin dosage (Figure 3). Infection brought about a 38-fold increase in 
expression of MCP-1 in the leptin-free samples, a 42-fold increase in the 10 ng/mL leptin sam-
ples, and a 41-fold increase in the 100 ng/mL leptin samples. The primary function of the mono-
cyte chemotactic protein (MCP-1) is to recruit monocytes to the site of infection so as to clear 
out virus particles and dead cell debris13—a process crucial to a functional non-specific immune 
defense. It has already been demonstrated that leptin secretion has a negative effect on regulatory 
T-cell proliferation14, and it is now evident that leptin negatively affects monocyte recruitment.  
Figure 3. Effects of leptin on human alveolar lung tissue expression of the MCP-1 gene after 8, 
24, and 48  hours of influenza A/PR8 virus infection, measured by quantitative RT-PCR from to-
tal RNA. After 48 hours of infection, the leptin dosage as a significant effect on the increase of 
MCP-1 mRNA expression (p = 0.0028). 
Leptin dosage does not affect IL-6 gene expression after 24 hours of infection 
After 24 hours of A549 tissue infection, leptin had no effect on the expression of IL-6, a pro-
inflammatory cytokine (Figure 4). Though it has been demonstrated that IL-6 is a regulator of 
leptin production15, we intended to see if the reverse was also true. IL-6 mRNA transcripts were 
undetectable at 8 hours or at 48 hours (data not shown). 
#   
Figure 4. Effects of leptin on human alveolar lung tissue expression of the IL-6 gene after 24 
hours of influenza A/PR8 H1N1 infection. Infection had a significant effect on IL-6 gene ex-
pression; however, leptin dosage had no statistically significant effect on gene expression. 
Leptin has no effect on MCP-1 expression in canine kidney cells in the first 48 hours of infection 
Leptin had no clear effect on MCP-1 expression in MDCK cells at any point during the first 48 
hours of infection (Figure 5). MCP-1 gene transcripts were not detectable after 8 and 24 hours of 
infection, therefore only the 48-hour data are presented. 
#  
Figure 5. Effects of leptin on canine kidney tissue expression of the MCP-1 gene after 48 hours 
of influenza A/PR8 virus infection. 
 mRNA transcripts in A549 tissue for IL-6 were detectable only after 24 hours post-
infection. The only detectable mRNA samples for MDCK cells were for the MCP-1 gene at 48 
hours, which showed no trend. 
Leptin dosage has no significant effect on virus titers  
The differences between the virus titers of the control (0 ng/mL leptin) and obese (100 ng/mL 
leptin) samples were not statistically significant, so we can rule out virus dosage as the cause of 
differences in gene expression for cytokines tested. It should be noted that viral titer does not 
necessarily correlate with pathogenesis, as obese and lean mice infected with the same dosage of 
influenza virus can have similar lung virus titers, yet the obese mice will exhibit severe lung 
pathology and high mortality rates compared to the lean animals.  
V. Discussion 
 As leptin was discovered only 20 years ago, we still have much to learn about its roles                 
in the body. It was once thought to simply be a bodyweight-regulating hormone, but then it was 
shown to have immunomodulating properties, and we believe that its roles are even broader than 
have been shown thus far. High leptin exposure results in the weakening of the cell’s natural abi-
lity to ward off infection (reduced interferons alpha and beta expression) and the cell’s ability to 
recruit immune cells to clear the virus (reduced MCP-1 expression). 
  Now that we have identified leptin as an enhancer of viral replication by diminishing                 
the anti-viral protective mechanisms used by the lung’s epithelial cells, we can explain, in part, 
why obesity is associated with more severe influenza lung pathology. This project is the first to 
show that leptin can directly alter the lung epithelial cell response to influenza infection in hu-
mans. Such findings are of great clinical significance; it has been shown that anti-leptin anti-
bodies can improve survival of obese mice when infected with flu14, and this project provides 
further evidence to why that may be. As around 5-20% of the US population becomes infected 
with the flu each year13, the public health implications of this research can have a profound im-
pact on how the disease and other infections are treated in obese persons in the future. 
 Future studies should look at the expression of other cytokines involved in innate                 
immunity, such as IL-1 or TNFα; other tissues infected by the influenza virus, such as nasal epi-
thelia or bronchial epithelia; and different concentrations of leptin not used in this study. In addi-
tion, different strains of flu at different doses can be tested to see if certain strains or doses pro-
duce different effects. These studies should also use tissues that express cytokines at significant 
levels in order to gather measurable results. 
 To answer our question of whether leptin affects only the immune response or if                 
it also directly affects the infected tissue, it is evident that leptin has an inhibiting effect on 
the expression of cytokines necessary for a proper antiviral defense. 
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